CN Patent

CN107530308A — 用于治疗或降低心血管风险的包含etc1002及一种或多种他汀类药物的固定剂量组合

Assigned to Esperion Therapeutics Inc · Expires 2018-01-02 · 8y expired

What this patent protects

本文公开的是包含固定剂量的ETC‑1002和一种或多种他汀类药物的组合物。本文还公开了用于使用固定剂量的ETC‑1002和一种或多种他汀类药物的方法。用途包括在受试者中治疗心血管疾病或降低心血管疾病风险的方法。用途还包括在受试者中治疗高胆固醇血症的方法。

USPTO Abstract

本文公开的是包含固定剂量的ETC‑1002和一种或多种他汀类药物的组合物。本文还公开了用于使用固定剂量的ETC‑1002和一种或多种他汀类药物的方法。用途包括在受试者中治疗心血管疾病或降低心血管疾病风险的方法。用途还包括在受试者中治疗高胆固醇血症的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN107530308A
Jurisdiction
CN
Classification
—
Expires
2018-01-02
Drug substance claim
No
Drug product claim
No
Assignee
Esperion Therapeutics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.